Form 4 Tracker
John D Quisel

Director; Director, Chief Executive Officer · 8 filings · Latest: Sep 23, 2026

Disc Medicine, Inc.
Gossamer Bio, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
IRON
John D QuiselDirector, Chief Executive OfficerSep 15, 2026
Option Exercise
$1.0136,000$36.4K262,064
IRON
John D QuiselDirector, Chief Executive OfficerAug 17, 2026
Sale
$79.1533,000$2.6M226,064
IRON
John D QuiselDirector, Chief Executive OfficerAug 17, 2026
Option Exercise
$13.5033,000$445.5K259,064
IRON
JOHN QUISEL—Aug 17, 2026
Proposed Sale
$78.8433,000$2.6M—
IRON
John D QuiselDirector, Chief Executive OfficerJul 13, 2026
Sale
$74.9633,000$2.5M226,064
IRON
John D QuiselDirector, Chief Executive OfficerJul 13, 2026
Option Exercise
$10.6833,000$352.4K259,064
IRON
JOHN QUISEL—Jul 13, 2026
Proposed Sale
$76.5933,000$2.5M—
IRON
John D QuiselDirector, Chief Executive OfficerJun 18, 2026
Sale
$70.2134,000$2.4M226,064
IRON
John D QuiselDirector, Chief Executive OfficerJun 18, 2026
Option Exercise
$9.8634,000$335.2K260,064
IRON
JOHN QUISEL—Jun 18, 2026
Proposed Sale
$70.2134,000$2.4M—
IRON
John D QuiselDirector, Chief Executive OfficerFeb 17, 2026
Sale
$62.8613,264$833.8K226,064
IRON
Quisel John D—Feb 17, 2026
Proposed Sale
$55.9513,264$742.1K—
IRON
JOHN QUISEL—Dec 11, 2025
Proposed Sale
$92.8540,000$3.7M—
IRON
JOHN QUISEL—Jul 9, 2025
Proposed Sale
$52.9734,800$1.8M—
IRON
JOHN QUISEL—Jul 3, 2025
Proposed Sale
$53.175,200$276.5K—
IRON
JOHN QUISEL—Dec 30, 2024
Proposed Sale
$64.1213,012$834.3K—
IRON
JOHN QUISEL—Dec 23, 2024
Proposed Sale
$64.5019,820$1.3M—
IRON
JOHN QUISEL—Dec 16, 2024
Proposed Sale
$64.8912,791$830.0K—